FDA Clears XableCath Blunt Tip Catheter

The FDA cleared XableCath’s blunt tip support catheter indicated for treating peripheral arterial disease.

The catheter is designed to facilitate over-the-wire the passage of true lumen through lesions above and below the knee in the peripheral vasculature.

The company said it expects for the device to be used in the first U.S. surgical procedures during the first half of 2018.